Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.
作者信息
Gottschalk S
机构信息
Department of Pediatrics and Immunology, Center for Cell and Gene Therapy, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
出版信息
Bone Marrow Transplant. 2011 Jan;46(1):18-9. doi: 10.1038/bmt.2010.258. Epub 2010 Oct 18.
PMID:20956953
Abstract
摘要
相似文献
1
Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated.
Bone Marrow Transplant. 2011 Jan;46(1):18-9. doi: 10.1038/bmt.2010.258. Epub 2010 Oct 18.
2
T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
J Clin Pathol. 2012 Mar;65(3):278-82. doi: 10.1136/jclinpath-2011-200523. Epub 2012 Jan 13.
3
[Chronic Epstein-Barr virus infection].
Nihon Rinsho. 2005 Apr;63 Suppl 4:503-7.
4
Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Eur J Immunol. 2006 Mar;36(3):593-602. doi: 10.1002/eji.200535485.
5
Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Am J Hematol. 2008 Sep;83(9):721-7. doi: 10.1002/ajh.21247.
6
Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.
Lancet. 2000 Jul 15;356(9225):223-4. doi: 10.1016/S0140-6736(00)02488-0.
7
Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.
Bone Marrow Transplant. 2011 Jan;46(1):77-83. doi: 10.1038/bmt.2010.122. Epub 2010 May 24.
8
Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Bone Marrow Transplant. 2003 Jan;31(2):105-11. doi: 10.1038/sj.bmt.1703796.
9
[Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
Rinsho Ketsueki. 2008 Jun;49(6):390-6.
10
Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Rev Med Virol. 2006 Jul-Aug;16(4):251-61. doi: 10.1002/rmv.505.
Zotero 插件